Free Trial

Aspen Aerogels, Inc. (NYSE:ASPN) Given Average Rating of "Buy" by Brokerages

Aspen Aerogels logo with Construction background

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has been assigned an average recommendation of "Buy" from the ten research firms that are covering the stock, MarketBeat.com reports. Nine analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $28.70.

ASPN has been the subject of several analyst reports. StockNews.com upgraded shares of Aspen Aerogels to a "sell" rating in a research report on Wednesday, November 13th. Barclays cut their target price on Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a research note on Tuesday, November 12th. Piper Sandler decreased their price target on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. HC Wainwright restated a "buy" rating and set a $30.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Finally, Roth Mkm decreased their target price on Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating on the stock in a research report on Friday, November 8th.

Read Our Latest Stock Analysis on ASPN

Insider Transactions at Aspen Aerogels

In related news, CEO Donald R. Young sold 63,355 shares of the firm's stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares of the company's stock, valued at $14,523,709.20. This trade represents a 11.58 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 4.30% of the company's stock.

Institutional Investors Weigh In On Aspen Aerogels

A number of institutional investors have recently made changes to their positions in ASPN. Bank of New York Mellon Corp boosted its stake in shares of Aspen Aerogels by 26.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 226,666 shares of the construction company's stock valued at $5,406,000 after purchasing an additional 46,988 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Aspen Aerogels by 10.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company's stock worth $341,000 after acquiring an additional 1,339 shares during the period. nVerses Capital LLC bought a new position in shares of Aspen Aerogels in the 2nd quarter worth about $95,000. Rhumbline Advisers lifted its stake in shares of Aspen Aerogels by 13.7% in the 2nd quarter. Rhumbline Advisers now owns 93,226 shares of the construction company's stock valued at $2,223,000 after purchasing an additional 11,205 shares during the period. Finally, Victory Capital Management Inc. bought a new stake in shares of Aspen Aerogels during the 2nd quarter valued at about $230,000. Institutional investors own 97.64% of the company's stock.

Aspen Aerogels Price Performance

Shares of NYSE ASPN traded up $0.49 during mid-day trading on Thursday, reaching $12.39. The company had a trading volume of 1,262,982 shares, compared to its average volume of 1,628,585. The firm has a market cap of $1.02 billion, a price-to-earnings ratio of 1,240.24 and a beta of 2.12. The business's 50-day simple moving average is $15.62 and its 200 day simple moving average is $21.95. Aspen Aerogels has a one year low of $10.75 and a one year high of $33.15. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93.

About Aspen Aerogels

(Get Free Report

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Further Reading

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines